AstriVax Therapeutics

Quick facts

Phase 1 pipeline

• AVX70120 high dose level
• AVX70120 low dose level
• AVX70120 middle dose level
• AVX70371
• AVX70481 high dose level
• AVX70481 low dose level
• AVX70481 middle dose level

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• AstriVax Therapeutics portfolio CI brief
• AstriVax Therapeutics pipeline updates RSS